According to Straits Research, the global nuclear medicine market is projected to witness significant growth, expanding from a valuation of USD 17.19 billion in 2025 to USD 40.18 billion by 2033. The market, which was valued at USD 15.46 billion in 2024, is anticipated to grow at an impressive CAGR of 11.2% during the forecast period from 2025 to 2033.

Key Drivers in the Nuclear Medicine Market

The nuclear medicine market is being driven by several factors, including:

• Increased prevalence of chronic diseases such as cancer and cardiovascular conditions.
• Rising adoption of advanced imaging technologies.
• Growing awareness about the benefits of nuclear medicine for diagnostic and therapeutic applications.
• Technological advancements in radiopharmaceutical production and delivery.
• Expanding investments in healthcare infrastructure globally.

For a detailed insight, download the full PDF sample copy of the report: https://straitsresearch.com/report/nuclear-medicine-market/request-sample

Key Developments in the Nuclear Medicine Market

The nuclear medicine industry has experienced notable advancements, including the development of innovative radiopharmaceuticals, enhanced imaging modalities, and improvements in isotope production techniques. These developments aim to address the increasing demand for precise diagnostics and effective treatments across various medical fields.

Market Segmentation Analysis

By Type

1. Diagnostic Nuclear Medicine
   • SPECT Radiopharmaceuticals
     • Technetium-99m
     • Thallium-201
     • Gallium-67
     • Iodine-123
     • Other SPECT Isotopes
   • PET Radiopharmaceuticals
     • F-18
     • Ru-82
     • Other PET Isotopes
2. Therapeutic Nuclear Medicine
   • Alpha Emitters
     • Ra-223
   • Beta Emitters
     • Iodine-131
     • Yttrium-90
     • Samarium-153
     • Lutetium-177
     • Rhenium-186
     • Other Beta Emitters
3. Brachytherapy Isotopes
   • Iodine-125
   • Palladium-103
   • Cesium-131
   • Iridium-192
   • Other Brachytherapy Isotopes

By Application

1. Diagnostic Applications
   • SPECT Applications
     • Cardiology
     • Bone Scans
     • Thyroid Applications
     • Pulmonary Scans
     • Other SPECT Applications
   • PET Applications
     • Oncology
     • Cardiology
     • Neurology
     • Other PET Applications
2. Therapeutic Applications
   • Thyroid Indications
   • Bone Metastasis
   • Lymphoma
   • Endocrine Tumors
   • Other Indications

By End-User

• Hospitals
• Imaging Centers
• Academic and Research Centers
• Others

By Modality

• SPECT
• PET
• Alpha-emitters
• Beta-emitters
• Brachytherapy

Access detailed segmentation analysis here: https://straitsresearch.com/report/nuclear-medicine-market/segmentation

Top Key Players in the Nuclear Medicine Market

Leading companies contributing to the growth of the nuclear medicine market include:

1. Curium Pharma
2. Nordion INC.
3. Eckert & Ziegler Group
4. GE Healthcare
5. Bracco Imaging S.p.A
6. Bayer AG
7. Eczacıbaşı-Monrol Nuclear Products
8. Mallinckrodt plc
9. North Star Medical Radioisotopes
10. Sinotau Pharmaceuticals
11. SHINE Medical Technologies
12. Global Medical Solutions
13. Ltd.

Key Insights and Opportunities

• The diagnostic nuclear medicine segment is expected to dominate the market, driven by the increasing prevalence of cancer and cardiovascular diseases.
• Therapeutic nuclear medicine is anticipated to gain traction due to the growing adoption of targeted therapies and alpha-emitter treatments.
• Rising investments in research and development are creating opportunities for novel radiopharmaceuticals and advanced imaging solutions.

For inquiries, customization requests, or additional details, visit: https://straitsresearch.com/buy-now/nuclear-medicine-market

About Straits Research

Straits Research is a leading provider of business intelligence, specializing in research, analytics, and advisory services. With a commitment to delivering comprehensive insights, Straits Research empowers organizations to make informed decisions and drive growth in competitive markets.

Contact Us

Email: [email protected]
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)